For Doctors: Developing Your Hormone Therapy Practice
While the latest trend in women’s health and hormone therapy is to prescribe the lowest dose for the least duration of time, Women’s Health America (WHA) has helped physicians provide this type of cutting-edge care for their patients since nearly 30 years ago. In fact, Women’s Health America has always been a pioneering the future of hormone therapy: *
Restore™ is the latest in their innovative programs designed to provide individualized bioidentical hormone therapy. Medicine for this millennium, *Restore™ integrates the very latest in leading laboratory technology and pharmaceutical science with traditional values in health care: listening to patients and responding to their individual needs. *Restore™ lets practitioners return to the art of patient care and treat patients as individuals. In the wake of the controversy over hormone replacement therapy, this approach is more important than ever.
“Our recommendation is… take the lowest dose for the least duration required to provide relief,” said Mark B. McClellan, M.D., Ph.D, Commissioner U.S. Food and Drug Administration in 2003. Dr. Leon Speroff, Professor of Obstetrics/Gynecology at Oregon Health & Science University adds, “As we move to lower doses, I believe clinicians will have to be more aggressive in providing appropriate surveillance.” That kind of monitoring is something time constraints keep most physicians with a busy practice from being able to provide directly for their patients. That’s where *Restore™ comes in – by providing this very type of careful monitoring now recommended by the FDA.
The secret to success:
Marla Ahlgrimm, Founder & CEO of Womens Health America
The secret to *Restore™’s success starts with Marla Ahlgrimm’s, R.Ph., founder and CEO of Women’s Health America, years of experience in using her own ability to carefully listen to physicians and patients. What she has learned and observed over the years is the basis for the state-of-the-art Hormone Therapy management protocols as well as the technology housed in Women’s Health America’s pristine headquarters in Madison, Wisconsin. There, Ahlgrimm and her staff, including several registered pharmacists, nurses, laboratory technicians, analytical chemists and a cadre of support staff evaluate health histories and hormone levels, dispense individualized prescription therapy, monitor outcomes and provide top-notch assistance to physicians and their patients with PMS,
perimenopause and
menopause concerns.
Physicians enrolled in the *Restore™ program provide their patients with a complete bio-identical hormone therapy program that combines salivary hormone level and NTx urine bone loss testing, customized prescription therapy, follow-up testing and ongoing case management.
This article originally appeared in the M.D. NEWS VOL.3, NO 1 JAN 2005
